Plössl K - Search Results

1

Effects of age on dopamine transporters in healthy humans.

Mozley PD, Acton PD, Barraclough ED, Plössl K, Gur RC, Alavi A, Mathur A, Saffer J, Kung HF. Mozley PD, et al. Among authors: plossl k. J Nucl Med. 1999 Nov;40(11):1812-7. J Nucl Med. 1999. PMID: 10565775 Free article.

2

Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography.

Acton PD, Choi SR, Plössl K, Kung HF. Acton PD, et al. Among authors: plossl k. Eur J Nucl Med Mol Imaging. 2002 May;29(5):691-8. doi: 10.1007/s00259-002-0776-7. Epub 2002 Mar 7. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976810

3

Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123]IBF.

Acton PD, Hou C, Kung MP, Plössl K, Keeney CL, Kung HF. Acton PD, et al. Among authors: plossl k. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1507-15. doi: 10.1007/s00259-002-0903-5. Eur J Nucl Med Mol Imaging. 2002. PMID: 12537007

4

Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.

Newberg AB, Plössl K, Mozley PD, Stubbs JB, Wintering N, Udeshi M, Alavi A, Kauppinen T, Kung HF. Newberg AB, et al. Among authors: plossl k. J Nucl Med. 2004 May;45(5):834-41. J Nucl Med. 2004. PMID: 15136634 Free article.

5

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.

Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H. Swanson RL, et al. Among authors: plossl k. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):302-7. doi: 10.1007/s00259-004-1667-x. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791439 Clinical Trial.

6

Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.

Acton PD, Newberg A, Plössl K, Mozley PD. Acton PD, et al. Among authors: plossl k. Phys Med Biol. 2006 Feb 7;51(3):575-85. doi: 10.1088/0031-9155/51/3/007. Epub 2006 Jan 11. Phys Med Biol. 2006. PMID: 16424582

7

Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.

Kung HF, Kim HJ, Kung MP, Meegalla SK, Plössl K, Lee HK. Kung HF, et al. Among authors: plossl k. Eur J Nucl Med. 1996 Nov;23(11):1527-30. doi: 10.1007/BF01254479. Eur J Nucl Med. 1996. PMID: 8854853

8

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.

Meegalla SK, Plössl K, Kung MP, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Meegalla SK, et al. Among authors: plossl k. J Med Chem. 1997 Jan 3;40(1):9-17. doi: 10.1021/jm960532j. J Med Chem. 1997. PMID: 9016323

9

[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.

Kung MP, Stevenson DA, Plössl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF. Kung MP, et al. Among authors: plossl k. Eur J Nucl Med. 1997 Apr;24(4):372-80. doi: 10.1007/BF00881808. Eur J Nucl Med. 1997. PMID: 9096087

10

Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.

Dresel SH, Kung MP, Plössl K, Meegalla SK, Kung HF. Dresel SH, et al. Among authors: plossl k. Eur J Nucl Med. 1998 Jan;25(1):31-9. doi: 10.1007/s002590050191. Eur J Nucl Med. 1998. PMID: 9396872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters